Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) has renewed two agreements to continue leasing certain property and assets from controlling shareholder Kelun Pharmaceutical for the three years ending Dec. 31, 2027, a Jan. 28 bourse filing said.

The leased properties in Chengdu, China, are being used by the company for its daily operations, such as for R&D activities, and as a storage house, office space, and staff housing solution.

The equipment comprises around 1,074 pieces of equipment including manufacturing and laboratory equipment and instruments.